TGM2 and myeloid sarcoma: In the study conducted by Tengah and others in the UK, no difference was observed in tTG-2Ab levels between patients with MS and healthy subjects.28 In the studies conducted in Iran,24,29 no differences were observed in the serological tests of tTG-2Ab between patients with MS and healthy controls.